CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS
$1,091,198FY2018Defense Health AgencyDOD
University Of Washington, Seattle WA
University Of Washington, Seattle WA